|
End-of-day quote
Taipei Exchange
18/11/2026
|
5-day change | 1st Jan Change | ||
| 52.50 TWD | +1.94% |
|
0.00% | -25.43% |
Company Valuation: PharmaEngine, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 10,207 | 17,961 | 15,158 | 12,974 | 10,115 | 7,543 | - |
| Change | - | 75.96% | -15.6% | -14.41% | -22.04% | -25.43% | - |
| Enterprise Value (EV) | 8,057 | 17,961 | 14,283 | 12,974 | 10,115 | 7,543 | 7,543 |
| Change | - | 122.93% | -20.48% | -9.16% | -22.04% | -25.43% | 0% |
| P/E | 24.7x | 56.3x | 55.2x | 7.42x | 26.2x | 14.1x | 14.7x |
| PBR | 2.67x | 4.64x | 3.92x | 2.4x | 2.05x | 1.5x | 1.47x |
| PEG | - | -2.3x | -4x | 0x | -0.3x | 0.4x | -3.42x |
| Capitalization / Revenue | 15.6x | 27.4x | 19.7x | 5.14x | 11.1x | 7.46x | 7.38x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 7.46x | 7.38x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 14.5x | 14x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | 2.7 | 2 | 1.5 | 6 | - | - | - |
| Rate of return | 3.72% | 1.6% | 1.42% | 6.64% | - | - | - |
| EPS 2 | 2.94 | 2.22 | 1.91 | 12.17 | 2.69 | 3.72 | 3.56 |
| Distribution rate | 91.8% | 90.1% | 78.5% | 49.3% | - | - | - |
| Net sales 1 | 654.8 | 654.4 | 767.7 | 2,523 | 911.4 | 1,011 | 1,022 |
| EBITDA | 373 | - | 286.2 | 2,062 | - | - | - |
| EBIT 1 | 362.7 | 282.7 | 277.2 | 2,053 | 425.5 | 521 | 539 |
| Net income 1 | 426 | 318.8 | 274.6 | 1,751 | 387.6 | 534 | 511 |
| Net Debt | -2,151 | - | -875.6 | - | - | - | - |
| Reference price 2 | 72.60 | 125.00 | 105.50 | 90.30 | 70.40 | 52.50 | 52.50 |
| Nbr of stocks (in thousands) | 140,596 | 143,687 | 143,679 | 143,678 | 143,678 | 143,678 | - |
| Announcement Date | 3/8/22 A | 3/17/23 A | 2/29/24 A | 2/27/25 A | 3/11/26 A | - | - |
1TWD in Million2TWD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 13.84x | - | - | - | 225M | ||
| 17.32x | 6.64x | 12.72x | 1.72% | 66.37B | ||
| 31.83x | 8.5x | 28.08x | 0.07% | 58.86B | ||
| 38.41x | 6.84x | 20.46x | 0.85% | 55.22B | ||
| 44.35x | 6.2x | 29.52x | -.--% | 47.21B | ||
| 33.62x | 3.22x | 13.9x | -.--% | 42.45B | ||
| 35.98x | 8.9x | 23.21x | 0.36% | 36.44B | ||
| -19.28x | 55.7x | -21.11x | -.--% | 35.19B | ||
| 41.59x | 8.02x | 26.91x | -.--% | 32.66B | ||
| -74.36x | 14.09x | -75.73x | -.--% | 26.73B | ||
| Average | 16.33x | 13.12x | 6.44x | 0.33% | 40B | |
| Weighted average by Cap. | 21.60x | 11.64x | 11.39x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4162 Stock
- Valuation PharmaEngine, Inc.
Select your edition
All financial news and data tailored to specific country editions
















